Abstract
The rapidly increasing elderly population poses a major challenge for future health-care systems. Many of the diseases of old age are neurological disorders, so neurological practice is likely to be disproportionately affected by an ageing society. However, as highlighted in two Reviews in this issue of The Lancet Neurology, there is a dearth of clinical trials among older people—indeed, very elderly patients are systematically excluded from many clinical trials. If we are to meet the challenge of caring for the rising numbers of elderly patients in the future, more good-quality trials in older people are needed to inform clinical practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
